Comparative efficacy of interventional therapy with or without targeted immunotherapy in Child-Pugh B hepatocellular carcinoma patients: a single-center, retrospective study
Interventional therapy combined with targeted and immunotherapy can be a safe and effective treatment for patients with Child-Pugh grade B hepatocellular carcinoma in the setting of controlled liver function impairment.
Authors
- Man Zhao (ORCID: https://orcid.org/0000-0001-7368-1079)
- Xufeng Guo (ORCID: https://orcid.org/0000-0001-5293-2828)
- Guang Yang (ORCID: https://orcid.org/0009-0004-5641-3143)
- Guangjie Han (ORCID: https://orcid.org/0000-0002-6921-7369)
- Jinfeng Wang (ORCID: https://orcid.org/0000-0002-6687-9420)
- Fei Yin (ORCID: https://orcid.org/0000-0003-2430-9267)
- Xin Han (ORCID: https://orcid.org/0000-0002-9176-1141)
- Jianfei Shi (ORCID: https://orcid.org/0000-0002-4891-6689)
- Xiaoling Duan
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3389/fonc.2025.1541805
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hebei Province
- Horizon 2020 Framework Programme